Natalie Wenske
Medical · Houston, TXNPI 1144595513
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 108 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 24.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,005 and has fallen 97.9% since, to $21 in 2025.
Across 108 payments — averaging $19.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Dexcom, Inc.$509
- Lilly USA, LLC$257
- AstraZeneca$158
- Bayer$145
- Novo Nordisk$126
- Amgen$98
- plus $830 from 21 others
What the payments were for
- Food & beverage$2,11299%
- Education$121%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Dexcom, Inc. | 19 | $509 |
| Lilly USA, LLC | 11 | $257 |
| AstraZeneca | 9 | $158 |
| Bayer | 6 | $145 |
| Novo Nordisk | 7 | $126 |
| Amgen | 5 | $98 |
| Amneal Pharmaceuticals LLC | 6 | $98 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $90 |
| Boehringer Ingelheim | 6 | $84 |
| Amarin Pharma, Inc. | 5 | $83 |
| AbbVie | 4 | $79 |
| Mannkind Corporation | 5 | $66 |
| Xeris Pharmaceuticals, Inc. | 3 | $48 |
| Astellas Pharma US Inc | 3 | $43 |
| Exact Sciences | 2 | $30 |
| GRT US Holding, Inc. | 1 | $26 |
| Antares Pharma, Inc. | 1 | $23 |
| Corcept Therapeutics | 1 | $21 |
| Embecta Corp. | 1 | $21 |
| Bigfoot Biomedical Inc | 1 | $18 |
| Ipsen Biopharmaceuticals, Inc | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| Recordati_rare_diseases_inc. | 1 | $15 |
| EUSA Pharma (US) LLC | 1 | $15 |
| Merck | 1 | $13 |
| Cequr Corporation | 1 | $13 |
| Ascend Therapeutics US, LLC | 1 | $12 |
How this compares
$2,124 in reported general payments places this provider in the 65th percentile of 1,490 medical providers in Texas.
Other medical in Houston
- Olga RodziyenskaHouston$65K
- Kathleen HoganHouston$26K
- Omni McCluneyHouston$18K
- Carl MayberryHouston$18K
- Carley BuddenbaumHouston$16K
- Mark DavisFort Worth$1M
- Joey Dixon-JulianBoerne$458K
- Terry FaleyeKingwood$243K
- Kimberly PoarchDallas$166K
- Erin DuhaimeDallas$150K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.